STOCK TITAN

Adicet Bio to Participate in Fireside Chat at the 7th Annual Truist Securities Life Sciences Summit

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology firm focused on allogeneic gamma delta T cell therapies for cancer, will have its CEO, Chen Schor, present at the 7th Annual Truist Securities Life Sciences Summit on May 4, 2021, at 2:40 PM ET. A live audio webcast of the event will be available on their investors website, with an archived replay accessible for 30 days post-presentation. Adicet Bio is advancing engineered gamma delta T cells aimed at improving tumor targeting and immune response in patients.

Positive
  • None.
Negative
  • None.

MENLO PARK, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced that Chen Schor, President and Chief Executive Officer, will present at the 7th Annual Truist Securities Life Sciences Summit on Tuesday, May 4, 2021 at 2:40 PM ET.

A live audio webcast of the fireside chat can be accessed on the Investors section of Adicet Bio’s website at https://investor.adicetbio.com. An archived replay will be available for 30 days following the presentation.

About Adicet Bio, Inc.
Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients. For more information, please visit our website at http://www.adicetbio.com.

Adicet Bio., Inc.
Investor and Media Contacts

Anne Bowdidge
abowdidge@adicetbio.com

Janhavi Mohite
Stern Investor Relations, Inc.
212-362-1200
janhavi.mohite@sternir.com


FAQ

What will Adicet Bio present at the Truist Securities Life Sciences Summit?

Adicet Bio's CEO, Chen Schor, will present at the summit on May 4, 2021.

When is Chen Schor's presentation at the Truist Securities Summit?

Chen Schor's presentation is scheduled for May 4, 2021, at 2:40 PM ET.

How can I access the Adicet Bio presentation webcast?

The live audio webcast can be accessed on Adicet Bio’s investors section of their website.

How long will the Adicet Bio presentation replay be available?

The archived replay of the presentation will be available for 30 days after the event.

What does Adicet Bio specialize in?

Adicet Bio specializes in developing allogeneic gamma delta T cell therapies for cancer and other diseases.

Adicet Bio, Inc.

NASDAQ:ACET

ACET Rankings

ACET Latest News

ACET Stock Data

78.28M
69.64M
1.59%
76.44%
4.16%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
BOSTON